GCC2 as a New Early Diagnostic Biomarker for Non-Small Cell Lung Cancer
No specific markers have been identified to detect non-small cell lung cancer (NSCLC) cell-derived exosomes circulating in the blood. Here, we report a new biomarker that distinguishes between cancer and non-cancer cell-derived exosomes. Exosomes isolated from patient plasmas at various pathological...
Guardado en:
Autores principales: | Hyesun Jeong, Byeong Hyeon Choi, JinA Park, Jik-Han Jung, Hyunku Shin, Ka-Won Kang, Yu Hua Quan, Jewon Yu, Ji-Ho Park, Yong Park, Yeonho Choi, Hyun Koo Kim, Sunghoi Hong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ec9c5250a33a43519fff7380f8888040 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Significance of Exosomes in Pathogenesis, Diagnosis, and Treatment of Esophageal Cancer
por: Jing Z, et al.
Publicado: (2021) -
Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer
por: Fang Yang, et al.
Publicado: (2021) -
Multiplexed Profiling of Extracellular Vesicles for Biomarker Development
por: Cheng Jiang, et al.
Publicado: (2021) -
Biomarkers for screening of lung cancer and pre-neoplastic lesions in a high risk Chilean population
por: Adonis,Marta I, et al.
Publicado: (2014) -
Research Progress on CircRNA in Liquid Biopsy of Gastric Cancer
por: ZHU Hao, et al.
Publicado: (2021)